Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data

April 25, 2024

Must read

Shares of Acrivon Therapeutics advanced in post-market trading after the biopharmaceutical company said it would present clinical trial data in connection with a biomarker test for ovarian and endometrial cancers.

Source link

Can You Get Paid to Go to College?

Treasury yields steady ahead of U.S. GDP data that sets stage for inflation report

Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data

Must read

Stocks may rise into the summer. These 3 risks could derail the rally.

Stay Prepared on the Road with This $80 Tire Inflator

The biggest earnings heavy hitter reports this week, and so do Target and other retailers

Optimize Your Remote Workflow with Maximum Connectivity for Just $55

More articles

LEAVE A REPLY Cancel reply

Latest article

Stocks may rise into the summer. These 3 risks could derail the rally.

Stay Prepared on the Road with This $80 Tire Inflator

The biggest earnings heavy hitter reports this week, and so do Target and other retailers

Optimize Your Remote Workflow with Maximum Connectivity for Just $55

Looking to place a wager on the Preakness? Here’s how to become a savvy bettor.

Usefull Links